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MAGNETIC RESONANCE IMAGING FEATURES
Tun-Mei Hong, Rheun-Chuan Lee, Jen-Huey Chiang, and Cheng-Yen Chang
Department of Radiology, Taipei Veterans General Hospital, Taiwan.
The aim of this study was to analyze the computerized tomography (CT) and magnetic
resonance imaging (MRI) features of intraductal papillary mucinous tumor (IPMT) of the
pancreas. The cases of eight patients with pathologically proven IPMT (1 papillary
hyperplasia, 7 adenocarcinoma) of the pancreas were retrospectively reviewed. There were
five men and three women with ages ranging from 42 to 82 years. Imaging studies included
six thin-section dynamic CT scans, seven MRI scans, one MR cholangiopancreatography scan,
and two endoscopic retrograde cholangiopancreatography scans. There was only one benign
IPMT, which presented as a unilocular cyst in the pancreatic body with no mural nodules
and no dilatation of the main pancreatic duct (MPD). All seven patients with malignant IPMT
had multilocular cysts with papillary projections in the pancreatic head and/or uncinate
process accompanied by dilated MPD (5 diffuse, 2 segmental). Communication between the
cystic lesions and the MPD were evident in all seven patients. One patient had small mural
nodules in the branch ducts of the pancreatic body and five had a bulging papilla with a
patulous orifice. A mass effect resulting in biliary obstruction was shown in one patient.
One patient had a ruptured cyst with mucin leakage into the right anterior pararenal space
following sono-guided aspiration. In conclusion, the main imaging feature of IPMT in our
patients was a multilocular cyst with papillary projections located in the pancreatic head
and uncinate process. Although CT and MRI cannot differentiate mucin content from
pancreatic juice, communication between the cystic lesion and the dilated MPD and a bulging
papilla with a patulous orifice are characteristics of IPMT.
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Intraductal papillary mucinous tumor (IPMT) of the
pancreas is uncommon and represents about 1–2% of
pancreatic exocrine tumors. It was first described by
Ohhashi et al in 1982 [1], and is characterized by
excretion of mucin through the patulous orifice of an
enlarged papilla of Vater and filling defects of mucin
and/or tumor in the pancreatic ducts on endoscopic
retrograde cholangiopancreatography (ERCP). Vari-
ous nomenclature was used before 1997, including
intraductal mucin-hypersecreting tumor, mucin-pro-
ducing tumor, mucinous ductal ectasia, or ductectatic
mucinous cystic tumor [2]. Histopathologically, IPMT
has a spectrum of abnormalities, including hyperplasia,
dysplasia, adenoma, and adenocarcinoma. Benign
IPMT may undergo malignant transformation over
time, often many years. In general, IPMT has a low
malignant potential and more favorable prognosis
than ductal adenocarcinoma and mucinous cystad-
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enocarcinoma [2, 3]. Recently, because of the more
frequent use of thin-section helical computerized tom-
o g r a p h y  ( C T )  a n d  m a g n e t i c  r e s o n a n c e
cholangiopancreatography (MRCP), IPMT is increas-
ingly recognized. Furthermore, MRCP may replace
the invasive ERCP for diagnosis of IPMT [4].
MATERIALS AND METHODS
Patients
Between November 1997 and December 2001, eight
patients (5 men and 3 women, aged 42–82 years, mean
71 years) with IPMT of the pancreas were encountered
at our hospital, documented by surgery (n = 4; 3
Whipple’s operation, 1 distal pancreatectomy) and
aspiration cytology (n = 4; 2 sonoguided, 2 ERCP).
Clinically, two patients were asymptomatic, with
pancreatic cystic lesions found on sonography during
health check-up. The other six patients presented with
epigastralgia (n = 4), repeated pancreatitis (2), diabetes
mellitus (2), body weight loss (1), and jaundice (1).
Serum levels of carcinoembryonic antigen (CEA) and
CA 19-9 were within normal limits in all patients.
H i s t o p a t h o l o g i c  f i n d i n g s  r e v e a l e d  s e v e n
adenocarcinomas and one papillary hyperplasia. Initial
imaging studies included six CT scans, seven magnetic
resonance imaging (MRI) scans, one MRCP, and two
ERCPs.
CT techniques
After non-contrast helical CT (Lightspeed QXi, GE
Medical Systems, Milwaukee, WI, USA, or Somatom
Plus 4, Siemens, Erlangen, Germany), post-contrast
dynamic CT using power injection (rate, 2.5 mL/sec,
100 mL ionic iodinated contrast medium, 300 mg/mL)
was performed in two-phase acquisition: the arterial
predominant phase (40 seconds after contrast injection;
collimation: 3.75–5 mm; FOV: 20 cm focusing on the
pancreas) and the portal phase (60–70 seconds after
contrast injection; collimation: 7.5 mm; FOV: 30–40
cm, from the liver dome to the kidney lower pole).
MR and MRCP techniques
MR images were obtained using a 1.5 T-imager (CVi,
GE Medical Systems, and Magnetom Vision, Siemens).
After acquisition of T1- and T2-weighted images, post-
contrast dynamic MRI using three-dimensional
gradient-recalled echo (3D GRE) sequence (TR/TE:
4.6–5.1/1.1–1.8 ms; flip angle: 10°; matrix: 160–192 x
256; FOV: 32 cm, one excitation) was performed with
arterial predominant, portal, and equilibrium phases,
at 15, 45, and 120 seconds after contrast injection
(gadolinium-diethylenediaminepentaacetic acid,
DTPA, injected manually at 0.1 mmol/kg). MRCP was
performed using SSFSE sequence in a GE CVi (TR:∞;
TE: 900 ms; 1 acquisition; matrix: 256 x 256) and HASTE
sequence in a Siemens Vision (TR:∞; TE: 1100 ms;
effective TE: 95 ms; 1 acquisition; matrix: 240 x 256).
Both thick-slab (30–50 mm) and thin-slab (4 mm)
coronal, oblique coronal, and oblique axial projections
with FOV of 20–24 cm were used. All images were
post-processed using both maximum intensity
projection and multiplanar reformatting techniques.
ERCP
A clinical endoscopist performed ERCP in the usual
fashion with selective cannulation and contrast
injection into the common bile duct (CBD) and the
pancreatic duct. The content was aspirated for cytologic
analysis.
Image analysis
Both CT and MR images were reviewed by two
radiologists (RCL, JHC) for the presence of diffuse or
segmental main pancreatic duct (MPD) dilatation (and
the maximal MPD diameter), cystic lesions (including
lesion location, shape, size, and visualization of
communication with the MPD), mural papillary
projections at the cystic lesion or the MPD, with or
without contrast enhancement, and a bulging papilla
with a patulous orifice. Lesions were divided into
three types according to tumor location and ductal
involvement: main-duct, branch-duct, and mixed.
RESULTS
Patient data and imaging findings are summarized in
the Table. All seven malignant IPMTs presented
similarly. Each patient had a multilocular cyst (3.5–10
cm) with mural tumor (5 mm–4 cm) in the pancreatic
head and/or uncinate process, which communicated
with the MPD (Figures 1a, 1b, and 2a) and was
accompanied by MPD dilatation, either diffuse (5
patients, 71%) or segmental (2, 29%), (maximal
diameter, 3–20 mm). There was only one benign IPMT,
which presented on CT image as a unilocular cyst in
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the pancreatic body with no visible mural nodule or
MPD dilatation (Figure 3). Contrast enhancement of
the mural tumor was noted in three IPMTs during
dynamic MRI; the other four were too small to be
identified on axial images but presented as small
filling defects on MRCP. The multilocular or unilocular
cyst was actually cystic dilatation of the branch
pancreatic ducts (BPDs). There were three branch-
duct (2 malignant, 1 benign) and five mixed IPMTs (all
malignant) in our series. The two malignant branch-
duct IPMTs were located in the uncinate process; one
had short segmental MPD dilatation, the other had a
minimally dilated MPD. Neither was associated with
mural nodules in the MPD or a papilla bulging into the
duodenal lumen. The former was documented as
branch-duct IPMT because the surgical specimen was
pathologically free of tumor in the MPD. The five
malignant mixed IPMTs all showed a bulging papilla
with a patulous orifice (Figures 4 and 2b). One
malignant mixed IPMT also exerted a mass effect and
possible parenchymal invasion that caused distal
common bile duct obstruction (Figure 4). Another
malignant IPMT had superimposed Klebsiel la
pneumoniae infection, documented after mucin culture
following sono-guided aspiration. In this patient, a
ruptured cyst with mucin leakage into the right anterior
pararenal space was found on MRI (Figure 2c).
The ERCP performed in two patients showed dila-
tation of the MPD and the BPD in the pancreatic head
and/or uncinate process, with amorphous filling
defects. Jelly-like material leaked from the patulous
orifice of the bulging papilla, the cytology of which
revealed a mucin pool with carcinoma cells.
DISCUSSION
IPMT typically manifests in patients in the seventh
decade of life, with a male-to-female ratio ranging
from 1 to 2.4. No related risk factors have been
investigated. Clinically, the main symptoms and signs
are abdominal pain and pancreatitis due to mucin
impaction and impaired outflow of pancreatic juice.
Diabetes mellitus and jaundice may also be observed,
Table. Patient and disease characteristics
Age/sex Dx Pathology Type Location CT/MRCP EM F/U
80/F Distal Hyperplasia Branch Body Cun (2 cm) – No recurrence
pancreactectomy
75/M ERCP Carcinoma Mixed Head Ms (20 mm), – Enlarge
Cmu (5 cm), N, D, P, S
66/M Whipple Carcinoma Mixed Head Md (11mm), – No recurrence
Cmu (5 cm), N, D, P, S
79/M Sono-guided Carcinoma Mixed Head Md (15 mm), Cmu (10 cm), + Rupture
aspiration cytology N, D, P, S
78/F ERCP Carcinoma Mixed Head Md (15 mm), Cmu (4 cm), + Invasive,
N, D, P, S, CBD dilatation expire
42/F Whipple Carcinoma Branch Head/ Ms (6 mm), + No recurrence
uncinate Cmu (9 cm), N, D
process
69/M Whipple Carcinoma Mixed Head Md (12 mm), – No recurrence
Cmu (3.5 cm), N, D, P
82/M Sono-guided Carcinoma Branch Uncinate Md (3 mm), – aspiration
process Cmu (3 cm), N, D cytology
Dx = diagnostic technique; CT = computerized tomography; MRCP = magnetic resonance cholangiopancreatography; EM = enhancement of
mural nodules; F/U = follow-up; F = female; C = cystic lesion (cystic dilatation of the branch duct); un = unilocular; – = absent; M = male;
ERCP = endoscopic retrograde cholangiopancreatography; M = main pancreatic duct dilatation; s = segmental; mu = multilocular; C+N = cyst
with mural nodule/papillary projection; C+D = cyst communicating with the main pancreatic duct; P = bulging papilla with patulous orifice;
S = side branch dilatation at the body, tail region; Whipple = Whipple’s operation; d = diffuse; + = present; CBD = common bile duct.
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as in two of our patients. Histopathologically, there is
proliferation of mucin-producing columnar epithelial
cells, with a wide range of malignant potential varying
from papillary hyperplasia to dysplasia and carci-
noma [2, 3]. Branch-duct IPMT usually occurs in the
head or uncinate process of the pancreas. It presents as
cystic dilatation of the BPD with a multilocular or
Figure 1a. A 42-year-old female with branch-duct intraductal
papillary mucinous tumor. Post-gadolinium enhanced magnetic
resonance image reveals a multilocular cyst with enhancing
mural tumor (long arrow) in the pancreatic head and uncinate
process.
Figure 1b. The communication (short arrow) between the cyst
and the short segmental dilated main pancreatic duct is obvious
on magnetic resonance cholangiopancreatography.
Figure 2a. A 79-year-old male with malignant mixed intraductal
papillary mucinous tumor. Non-contrast computerized
tomography (CT) scan reveals communication (arrow head)
between a multilocular cyst (C) and the dilated main pancreatic
duct (D) and a bulging papilla (arrow).
Figure 2c. Two days after sono-guided aspiration, a true-fast imaging
with steady state precession magnetic resonance image shows fluid
accumulation in the right anterior pararenal space (arrow), indicating
rupture of the dilated branch duct in the uncinate process.
Figure 2b. Non-contrast computerized tomography scan reveals
communication (arrow head) between a multilocular cyst (C) and
the dilated main pancreatic duct (D) and a bulging papilla
(arrow).
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unilocular architecture. More or less marked dilata-
tion of the MPD is associated with IPMT due to mucin
impaction of the drainage vessels for pancreatic juice,
especially when the tumor is located in the pancreatic
head. When branch-duct IPMT is accompanied by
MPD dilatation, mucin or pancreatic juice content in
the MPD cannot be distinguished using imaging.
However, two clues offer differentiation of branch-
duct from mixed IPMT. In addition to the absence of
mural tumor at the dilated MPD, the presence of a
bulging papilla with a patulous orifice is only seen in
main-duct IPMT.
ERCP was previously the diagnosis tool of choice
for IPMT, because it can demonstrate communication
between a cystic lesion and the MPD, mucin leaking
from the papilla, and filling defects in the MPD or
BPD. However, occasionally, reflux of the contrast
material due to excess mucin or an enlarged papillary
orifice hinders filling of the ductal tree. MRCP has
advantages over ERCP because it can demonstrate the
entire pancreatobiliary tree without contrast material.
Thin-slab MRCP can reveal small mural nodules or
papillary projection. Using multiplanar reformation,
communication between the MPD and dilated branch
ducts can be appreciated. The disadvantages of MRCP
compared with ERCP are poor detection of the mucin
content, which is isointense with pancreatic juice, and
the lack of mucin aspiration for cytology [5].
Characteristic CT and MRI features include a pa-
pilla bulging into the duodenal lumen, communica-
tion between a cystic lesion and the MPD, and papil-
lary projection within the dilated MPD or BPD [2, 3, 6–
8]. Using these criteria, we successfully diagnosed the
seven malignant IPMTs and excluded other cystic
lesions of the pancreas.
Differentiation of branch-duct IPMT from other
cystic tumors is possible, for example, mucinous cys-
tadenoma/cystadenocarcinoma rarely shows commu-
nication with the MPD. Differentiation of IPMT from
pseudocysts complicated by pancreatitis can be made
because of the architecture of small locules and pres-
ence of mucin plugs or papillary proliferations in
IPMT. Main-duct IPMT can be differentiated from
chronic pancreatitis because, in the latter, the contour
of the MPD is often beaded, associated with
parenchymal calcification or pancreatic duct stones,
but no definite papillary projections. Some clues occa-
sionally help differentiation between mural tumors
and mucin plugs. Mural tumors clearly attach to the
duct wall and show contrast enhancement on thin-
section axial images, while mucin plugs are located in
the gravity-dependent portion of the duct and do not
enhance after contrast administration [2].
Patients with benign IPMT can be followed with-
out undergoing surgery. In addition, the surgical strat-
egy may be altered by the grade of malignancy of
IPMT [9]. Therefore, radiologic differentiation between
benign and malignant IPMT is important in determin-
ing appropriate treatment. Taouli et al reported the
predictive signs of malignancy in a series of 36 patients
examined using helical CT, including presence of a
solid mass, dilatation of the MPD greater than 10 mm,
diffuse or multifocal involvement, and attenuating or
calcified intraluminal content [7, 8]. Irie et al noted
Figure 4. A 78-year-old female with malignant mixed intraductal
papillary mucinous tumor. Multiplanar reformatting of magnetic
resonance cholangiopancreatography clearly depicts a diffusely
dilated main pancreatic duct, as well as a dilated branch pancreatic
duct at the body and tail regions (arrow head). Note the bulging
papilla with patulous orifice (arrow) and marked common bile
duct dilatation due to extrinsic tumor compression.
Figure 3. Non-contrast computerized tomography scan
demonstrates a 2-cm unilocular cyst in the pancreatic body
(arrow) in an 80-year-old female. Note no main pancreatic duct
dilatation. Benign intraductal papillary mucinous tumor
(papillary hyperplasia) was found after distal pancreatectomy.
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that the presence of mural nodules is indicative of
malignancy and diffuse MPD dilatation with maximal
diameter greater than 15 mm is suggestive of malig-
nancy in main-duct IPMT; among branch-duct IPMTs,
malignant tumors tend to be larger than benign tumors,
and any MPD dilatation is strongly associated with
malignancy [10]. Fukukura et al and Kimura et al also
showed that a bulging papilla and MPD dilatation
favor malignancy. In our series, seven malignant
IPMTs, five mixed and two branch-duct IPMTs, all
presented as multilocular cystic dilatation of the BPD
(3.5–10 cm) with mural tumors (5 mm–4 cm) in the
pancreatic head/uncinate process, associated with
MPD dilatation (3–20 mm, more pronounced in mixed
IPMT) [6, 11]. A bulging papilla with a patulous orifice
was depicted in all malignant mixed IPMTs. One ma-
lignant mixed IPMT also exerted a mass effect and
parenchymal invasion, causing biliary obstruction.
The only benign branch-duct IPMT had a smaller cyst, no
definite mural nodule, and no associated MPD dilatation.
In the late stage of IPMT or postoperative
recurrence, the tumor may disseminate within the
p e r i t o n e u m  ( p e s u d o m y x o m a  p e r i t o n e i )  o r
retroperitoneum [3, 12]. In our series, there was one
malignant IPMT that had superimposed K pneumoniae
infection and mucin leakage into the right anterior
pararenal space following sono-guided aspiration.
Thus, needle aspiration may precipitate rupture of the
dilated BPD in IPMT, causing tumor dissemination.
In conclusion, though MRCP or thin-section CT
cannot detect the presence of mucin, the findings of
MPD dilatation, a multi- or unilocular cyst communi-
cating with the MPD, mural nodules or papillary
projections, and a bulging papilla with a patulous
orifice are characteristic of IPMT.
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